SB 875
Allows a pharmacist to select an interchangeable biological product when filling a biological product prescription
LR Number:
Last Action:
6/8/2016 - Signed by Governor
Journal Page:
Calendar Position:
Effective Date:
August 28, 2016
House Handler:

Current Bill Summary

SB 875 - This act allows a pharmacist filling a prescription order for a brand name biological product to select a less expensive interchangeable biological product if the substitute has been approved by the FDA to be an interchangeable biological product, the prescriber has communicated that a interchangeable biological product may be substituted, and the pharmacist informs the patient. Within five days of dispensing a biological product, the pharmacist shall communicate the name and manufacturer of the product to the prescriber, unless there is no FDA approved interchangeable biological product or a refill prescription is not changed from the product dispensed on the prior filling.

The Board of Pharmacy shall maintain a link on its website to a current list of all biological products determined by the FDA to be interchangeable with a specific biological product.

This act is identical to SCS/HCS/HBs 1366 & 1878 (2016).